Comments
Shares of Sun Pharmaceutical Industries moved up 1.09 per cent on Friday on the BSE.
The stock is up Rs 10.25 or 1.09 per cent at Rs 949.50.
CLSA has raised the target price to Rs 1,160 from Rs 1,130 and has maintained "high conviction buy".
It said that issues at unit Ranbaxy's Mohali plant are less severe than those at other plants undergoing remedial action.
It also added that resumption of operations at Mohali plant in the medium term could de-risk operations at Halol and Ohm Labs, and may provide an upside to the $250 mln synergies' estimate.
Comments
COMMENT NOW
Comments
Comments have to be in English, and in full sentences. They cannot be abusive or personal. Please abide by our community guidelines for posting your comments.
We have migrated to a new commenting platform. If you are already a registered user of TheHindu Businessline and logged in, you may continue to engage with our articles. If you do not have an account please register and login to post comments. Users can access their older comments by logging into their accounts on Vuukle.